Functional characterisation of novel analgesic product based on self-regulating drug carriers

International Journal of Pharmaceutics

Volumn 360, Issue 1-2, 2008, Pages 18-28

  Cevc, G ^a   Vierl, U ^a   Mazgareanu, S ^a  

^a IDEA AG   (Germany)

Author keywords

Diractin ; Drug delivery; Ketoprofen; Local application; Nonsteroidal anti inflammatory drug; NSAID; Targeted analgesic; Transfersome ; Ultradeformable lipid vesicle

Indexed keywords

2 PROPANOL; ALCOHOL; AMMONIA; BENZYL ALCOHOL; BUTYLCRESOL; CARBOMER; DIETHANOLAMINE; DIRACTIN; DISODIUM HYDROGEN PHOSPHATE; EDETATE SODIUM; GABRILEN; KETOPROFEN; LAVENDER OIL; METHYL PARABEN; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; PROPYL PARABEN; SODIUM DIHYDROGEN PHOSPHATE; SODIUM HYDROXIDE; TOGAL MOBIL GEL; TRANSFERSOME;

ANIMAL EXPERIMENT; ARTICLE; BOAR (MALE PIG); DRUG ABSORPTION; DRUG DIFFUSION; DRUG UPTAKE; GEL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIPID VESICLE; MALE; NONHUMAN; PRIORITY JOURNAL; SKIN CAPILLARY; SUBCUTANEOUS TISSUE;

ADMINISTRATION, TOPICAL; ALGORITHMS; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL TRANSPORT, ACTIVE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIFFUSION; DIFFUSION CHAMBERS, CULTURE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GELS; HUMANS; KETOPROFEN; MALE; PARTICLE SIZE; SKIN ABSORPTION; SPECTROPHOTOMETRY, ULTRAVIOLET; SUSPENSIONS; SWINE;

EID: 47049115507     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.04.002     Document Type: Article

References (57)

1. Allen T.M., Hansen C.B., and Guo L.S.S. Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochim. Biophys. Acta 1150 (1993) 9-16
2. Benson H.A.E. Transdermal drug delivery: penetration enhancement techniques. Curr. Drug Deliv. 2 (2005) 23-33
3. Bock U., Krause W., Otto J., and Haltner E. Comparative in vitro and in vivo studies on the permeation and penetration of ketoprofen and ibuprofen in human skin (Article in German). Arzneimittelforschung 54 (2004) 522-529
4. Boutsiouki P., Thompson J.P., and Clough G.F. Effects of local blood flow on the percutaneous absorption of the organophosphorus compound malathion: a microdialysis study in man. Arch. Toxicol. 75 (2001) 321-328
5. Ceschel G.C., Maffei P., and Lombardi Borgia S. Correlation between the transdermal permeation of ketoprofen and its solubility in mixtures of a pH 6.5 phosphate buffer and various Solvents. Drug Deliv. 9 (2002) 39-45
6. Cevc, G., 1995. Material transport across permeability barriers by means of lipid vesicles. In: Hoff, A.V. (Series Ed.), Lipowsky, R., Sackmann, E. (Volume Eds.), Handbook of Biological Physics, vol. I, North-Holland, pp. 465-490 (Chapter 9).
7. Cevc G. Lipid suspensions on the skin. Permeation enhancement, vesicle penetration and transdermal drug delivery. Crit. Rev. Ther. Drug Carr. Syst. 13 (1996) 257-388
8. Cevc G. Drug delivery across the skin. Exp. Opin. Invest. Drugs 6 (1997) 1887-1937
9. ®-innovative transdermal drug carriers. In: Rathbone M., Roberts M., and Hadgraft J. (Eds). Modified Release Drug Delivery Technology (2002), M. Dekker, New York 533-546
10. ®. Clin. Pharmacokin. 42 (2003) 461-474
11. Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev. 56 (2004) 675-711
12. Cevc G., and Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta 1104 (1992) 226-232
13. Cevc G., and Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers. Transfersomes. Biochim. Biophys. Acta 1514 (2001) 191-205
14. ®, have an increased biological potency and reduced therapeutic dosages. Biochim. Biophys. Acta 1663 (2004) 61-73
15. Cevc G., and Gebauer D. Hydration driven transport of deformable lipid vesicles through fine pores and the skin barrier. Biophys. J. 84 (2003) 1010-1024
16. Cevc G., Gebauer D., Stieber J., Schätzlein A., and Blume G. Ultraflexible vesicles, Transfersomes, have an extremely low permeation resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim. Biophys. Acta 1368 (1998) 201-215
17. Cevc G., Mazgareanu S., and Rother M. Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels. Int. J. Pharm. 360 (2008) 29-39
18. Cevc G., Mazgareanu U., and Rother M. Vierl, U. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations. Int. J. Pharm. 359 (2008) 190-197
19. Cevc G., Schätzlein A., and Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers intact. Evidence from double Label CLSM Experiments and direct size measurements. Biochim. Biophys. Acta 1564 (2002) 21-30
20. ®, liposomes or mixed lipid micelles. Langmuir 19 (2003) 10753-10763
21. Cevc, G., Vierl, U., 2003. Aggregates with increased deformability, comprising at least three amphiphats .... European Patent No. 03,757,944.8 (PCT/EP03/11202).
22. Dowling T.C., Arjomand M., Lin E.T., Allen Jr. L.V., and McPherson M.L. Relative bioavailability of ketoprofen 20% in a poloxamer-lecithin organogel. Am. J. Health Syst. Pharm. 61 (2004) 2541-2544
23. El-Kattan A.F., Asbill C.S., Kim N., and Michniak B.B. Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations. Drug Deliv. 7 (2000) 147-153
24. ® formulation in comparison to a commercial triamcinolone acetonide formulation. Br. J. Dermatol. 149 (2003) 611-619
25. Frisken B.J., Asman C., and Patty P.J. Studies of vesicle extrusion. Langmuir 16 (2000) 928-933
26. Hadgraft J., de Plessis J., and Goosen C. The selection of non-steroidal anti-inflammatory agents for dermal delivery. Int. J. Pharm. 207 (2000) 31-37
27. Heyneman C.A., Lawless-Liday C., and Wall G.C. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs 60 (2000) 555-574
28. Higaki K., Asai M., Suyama T., Nakayama K., Ogawara K., and Kimura T. Estimation of intradermal disposition kinetics of drugs: II. Factors determining penetration of drugs from viable skin to muscular layer. Int. J. Pharm. 239 (2002) 129-141
29. Honeywell-Nguyen P.L., Gooris G.S., and Bouwstra J.A. Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J. Invest. Dermatol. 123 (2004) 902-910
30. Jaeckle E., Schaefer U.F., and Loth H. Comparison of effects of different ointment bases on the penetration of ketoprofen through heat-separated human epidermis and artificial lipid barriers. J. Pharm. Sci. 92 (2003) 1396-1406
31. Karande P., Jain A., Ergun K., Kispersky V., and Mitragotri S. Design principles of chemical penetration enhancers for transdermal drug delivery. Proc. Nat. Acad. Sci. (USA) 102 (2005) 4688-4693
32. Kommuru T.R., Khan M.A., and Reddy I.K. Racemate and enantiomers of ketoprofen: Phase diagram, thermodynamic studies, skin permeability, and use of chiral permeation enhancers. J. Pharm. Sci. 87 (2000) 833-840
33. Kretsos K., and Kasting G.B. Dermal capillary clearance: physiology and modelling. Skin Pharmacol. Physiol. 18 (2005) 55-74
34. Kretsos K., Kasting G.B., and Nitsche J.M. Distributed diffusion-clearance model for transient drug distribution within the skin. J. Pharm. Sci. 93 (2004) 2820-2835
35. Lasch J., and Bouwstra J. Interactions of external lipids (lipid vesicles) with the skin. J. Liposome Res. 5 (1995) 543-569
36. Loden M., Akerstrom U., Lindahl K., and Berne B. Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration. Int. J. Pharm. 284 (2004) 23-30
37. Maestrelli F., Gonzalez-Rodriguez M.L., Rabasco A.M., and Mura P. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery. Int. J. Pharm. 298 (2005) 55-67
38. Mitragotri S., Johnson M.E., Blankschtein D., and Langer R. An analysis of the size selectivity of solute partitioning, diffusion, and permeation across lipid bilayers. Biophys. J. 77 (1999) 1268-1283
39. Monteiro-Riviere N.A., Inman A.O., Riviere J.E., and McNeil S.C. Topical penetration of piroxicam is dependent on the distribution of the local cutaneous vasculature. Pharm. Res. 10 (1993) 1326-1331
40. Morgan C.J., Renwick A.G., and Friedmann P.S. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br. J. Dermatol. 148 (2003) 434-443
41. Nishihata T., Kotera K., Nakano Y., and Yamazaki M. Rat percutaneous transport of diclofenac and influence of hydrogenated soy phospholipids. Chem. Pharm. Bull. 35 (1987) 3807-3812
42. Paolino D., Lucania G., Mardente D., Alhaique F., and Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J. Control. Release 106 (2005) 99-110
43. Ricci M., Puglia C., Bonina F., Di Giovanni C., Giovagnoli S., and Rossi C. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. J. Pharm. Sci. 94 (2005) 1149-1159
44. Rhee Y.S., Choi J.G., Park E.S., and Chi S.C. Transdermal delivery of ketoprofen using microemulsions. Int. J. Pharm. 228 (2001) 161-170
45. Rhee G.J., Woo J.S., Hwang S.-J., Lee Y.W., and Lee C.H. Topical oleo-hydrogel preparation of ketoprofen with enhanced skin permeability. Drug Dev. Ind. Pharm. 25 (1999) 717-726
46. Schätzlein A., and Cevc G. Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes). Br. J. Dermatol. 138 (1998) 583-592
47. Shah A.K., Wei G., Lanman R.C., Bhargava V.O., and Weir S.J. Percutaneous absorption of ketoprofen from different anatomical sites in man. Pharm. Res. 13 (1996) 168-172
48. Singh P., and Roberts M.S. Blood flow measurements in skin and underlying tissues by microsphere method: application to dermal pharmacokinetics of polar nonelectrolytes. J. Pharm. Sci. 82 (1993) 873-879
49. Singh P., and Roberts M.S. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J. Pharmacol. Exp. Ther. 268 (1994) 144-151
50. Singh P., and Roberts M.S. Dermal and underlying tissue pharmacokinetics of lidocaine after topical application. J. Pharm. Sci. 83 (1994) 774-782
51. Trottet L., Merly C., Mirza M., Hadgraft J., and Davis A.F. Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride. Int. J. Pharm. 274 (2004) 213-219
52. Valenta C., Wanka M., and Heidlas J. Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug. J. Control. Release 63 (2000) 165-173
53. Van den Bergh B.A.I., Bouwstra J.A., Junginger H.E., and Wertz P.W. Elasticity of vesicles affects hairless mouse skin structure and permeability. J. Control Release 62 (1999) 367-379
54. Van den Bergh B.A.I., Vroom J., Gerritsen H., Junginger H.E., and Bouwstra J.A. Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy. Biochim. Biophys. Acta 1461 (1999) 155-173
55. Vincent C.M., Laugel C., and Marty J.P. In vitro topical delivery of non-steroidal anti-inflammatory drugs through human skin. Arzneimittelforschung 49 (1999) 509-513
56. In: Walters K.A., and Hadgraft J. (Eds). Pharmaceutical Skin Penetration Enhancement (1993), Marcel Dekker, New York
57. Wu P.C., Chang J.S., Huang Y.B., Chai C.Y., and Tsai Y.H. Evaluation of percutaneous absorption and skin irritation of ketoprofen through rat skin: In vitro and in vivo study. Int. J. Pharm. 222 (2001) 225-235